Challenges of Introducing Medicines Across EU Member States.

Timely and equitable access to new medicines across all 27 EU member states has been a top priority for the European Commission, but bridging the gap in access is a Herculean task as Eastern European countries only see a small fraction of the new drugs that launch across wealthier countries like Germany and Austria.